Article | December 1, 2021

Prepare For The PhRMA Code On Interactions Revisions

Source: Pro-ficiency
Regulatory & Ethical Considerations in a Pediatric Trial

The PhRMA Code is a voluntary code of ethics, relating to interactions pharmaceutical companies have with U.S. healthcare professionals. This code provides a collection of detailed rules, as well as broader principles, that have yet to be compiled into a comparable industry or government document.

PhRMA has adjusted its Code on Interactions, partly in response to the Special Fraud Alert issued by the OIG. These changes largely pertain to company-sponsored speaker programs, highlighting fraud and abuse risks with these events. The update was initially announced on August 6, 2021, and will take effect on January 1, 2022.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader